These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 32268235)

  • 1. Advancements in prophylactic and therapeutic nanovaccines.
    Bhardwaj P; Bhatia E; Sharma S; Ahamad N; Banerjee R
    Acta Biomater; 2020 May; 108():1-21. PubMed ID: 32268235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases.
    Gao X; Wang X; Li S; Saif Ur Rahman M; Xu S; Liu Y
    ACS Nano; 2023 Dec; 17(24):24514-24538. PubMed ID: 38055649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses.
    Yin Q; Wang Y; Xiang Y; Xu F
    Hum Vaccin Immunother; 2022 Nov; 18(6):2119020. PubMed ID: 36170662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Glance on Nanovaccine: A Potential Approach for Disease Prevention.
    Garg A; Agrawal R; Chopra H; Singh T; Chaudhary R; Tankara A
    Curr Pharm Biotechnol; 2024; 25(11):1406-1418. PubMed ID: 37861010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy.
    Jahanafrooz Z; Oroojalian F; Mokhtarzadeh A; Rahdar A; Díez-Pascual AM
    Drug Dev Res; 2024 Aug; 85(5):e22244. PubMed ID: 39138855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanovaccines: A game changing approach in the fight against infectious diseases.
    Priyanka ; Abusalah MAH; Chopra H; Sharma A; Mustafa SA; Choudhary OP; Sharma M; Dhawan M; Khosla R; Loshali A; Sundriyal A; Saini J
    Biomed Pharmacother; 2023 Nov; 167():115597. PubMed ID: 37783148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-adjuvanting cancer nanovaccines.
    Liao Z; Huang J; Lo PC; Lovell JF; Jin H; Yang K
    J Nanobiotechnology; 2022 Jul; 20(1):345. PubMed ID: 35883176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections.
    Chen H; Li Y; Li L; Yang Z; Wen Z; Liu L; Liu H; Chen Y
    Acta Biomater; 2023 Mar; 158():525-534. PubMed ID: 36572250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanovaccines: An effective therapeutic approach for cancer therapy.
    Gurunathan S; Thangaraj P; Wang L; Cao Q; Kim JH
    Biomed Pharmacother; 2024 Jan; 170():115992. PubMed ID: 38070247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eliciting B cell immunity against infectious diseases using nanovaccines.
    Singh A
    Nat Nanotechnol; 2021 Jan; 16(1):16-24. PubMed ID: 33199883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection.
    Xu F; Yuan Y; Wang Y; Yin Q
    Biomed Pharmacother; 2023 Feb; 158():114117. PubMed ID: 36528914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic nanovaccines for immunotherapy.
    Luo M; Samandi LZ; Wang Z; Chen ZJ; Gao J
    J Control Release; 2017 Oct; 263():200-210. PubMed ID: 28336379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance.
    Xu Z; Zhou H; Li T; Yi Q; Thakur A; Zhang K; Ma X; Qin JJ; Yan Y
    Drug Resist Updat; 2024 Jul; 75():101098. PubMed ID: 38833804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials.
    Vijayan V; Mohapatra A; Uthaman S; Park IK
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31615112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanovaccine: A novel approach in immunization.
    Gheibi Hayat SM; Darroudi M
    J Cell Physiol; 2019 Aug; 234(8):12530-12536. PubMed ID: 30633361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rough Nanovaccines Boost Antitumor Immunity Through the Enhancement of Vaccination Cascade and Immunogenic Cell Death Induction.
    Zhao X; Zhang J; Chen B; Ding X; Zhao N; Xu FJ
    Small Methods; 2023 May; 7(5):e2201595. PubMed ID: 36869418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen.
    Hashemi Goradel N; Nemati M; Bakhshandeh A; Arashkia A; Negahdari B
    Int Immunopharmacol; 2023 Apr; 117():109887. PubMed ID: 36841155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of Nanovaccines for Disease Prevention in Cattle.
    Maina TW; Grego EA; Boggiatto PM; Sacco RE; Narasimhan B; McGill JL
    Front Bioeng Biotechnol; 2020; 8():608050. PubMed ID: 33363134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monophosphoryl lipid A-assembled nanovaccines enhance tumor immunotherapy.
    Li R; Hao Y; Pan W; Wang W; Min Y
    Acta Biomater; 2023 Nov; 171():482-494. PubMed ID: 37708924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses.
    Chen S; Yang L; Ou X; Li JY; Zi CT; Wang H; Hu JM; Liu Y
    J Nanobiotechnology; 2022 Jul; 20(1):320. PubMed ID: 35836236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.